Neuroscience
Neurotransmitter receptors function via various G-protein coupled and G-protein independent mechanisms that activate downstream intracellular signaling pathways such as cAMP/PKA, PI3K/AKT, phospholipase A2, and phospholipase C pathways. For instance, dopamine receptors act through adenylate cyclase to activate PKA and other signaling molecules, thereby mediate gene expression through the actions of CREB and other transcription factors. Other neurotransmitters such as NMDAR or AMPAR are associated with ion channels that control flux of Ca2+ and Na+, thus propagating the action potential across the post-synaptic neuron.
Dysfunctions in GABAergic/glutamatergic/serotonergic/dopaminergic pathways result in a broad range of neurological disorders such as chronic pain, neurodegenerative diseases, and insomnia, as well as mental disorders including schizophrenia, bipolar disorder, depression, and addiction.
- A8496 PaliperidoneTarget: 5-HT2 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|Histamine H1 ReceptorsSummary: Dopamine receptor antagonist
- B2075 AmbrisentanTarget: ETA ReceptorsSummary: ETA-receptor antagonist
- B2235 ClozapineTarget: 5-HT2 Receptors|D1 and D5 Receptors|D2 Receptors|D3 Receptors|5-HT1 Receptors|D4 ReceptorsSummary: 5-HT receptor antagonist
- B2232 AripiprazoleTarget: 5-HT1 ReceptorsSummary: 5-HT receptor partial agonist
- B1488 PramipexoleTarget: D2 Receptors|D3 Receptors|D4 ReceptorsSummary: Dopamine agonist
- B1483 FenoldopamTarget: D1 and D5 ReceptorsSummary: D1-like dopamine receptor partial agonist
- B1482 Dopamine HClSummary: Dopamine D1-5 receptors agonist
- B6506 SCH 23390 hydrochlorideTarget: dopamine receptor|5-HT1 Receptor|5-HT2 ReceptorSummary: dopamine receptor antagonist
- A3744 QuetiapineTarget: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptorSummary: Dopamine receptor antagonist